CDC recommends RSV shot for pregnant individuals
The CDC's Advisory Committee on Immunization Practices recommends that all individuals between 32 and 36 weeks pregnant receive the newly available bivalent RSV vaccine.
Stay updated with breaking news from Maternal Immunization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The CDC's Advisory Committee on Immunization Practices recommends that all individuals between 32 and 36 weeks pregnant receive the newly available bivalent RSV vaccine.
Results from an ongoing Phase 2 study in pregnant individuals showed the investigational vaccine, GBS6, was generally well-tolerated and generated robust maternal antibody responses that were efficiently transferred to infants The safety profile between the vaccine and placebo groups was similar in both the mothers and infants GBS6 maternal vaccination may offer meaningful protection against invasive GBS disease in newborns and young infants, based on a natural history study conducted in parallel to the Phase 2 study
Learn about medical professionals and families whose stories illustrate how far this field has come—and how much more progress is needed.
Two infections claim the lives of 200,000 infants each year. A unique vaccination method could reverse these tragic numbers.